Small animal models, particularly genetically engineered mice, are increasingly recognized as powerful discovery tools in cancer research. However, the potential of animal models has not yet fully been realized since they are often sacrificed to perform tissue analysis to determine the effects of therapy. Sacrificing prevents long-term, in vivo observation of natural or perturbed processes. Therefore, there is a need for a morphologic, functional, cellular/molecular, and quantitative imaging technique capable of visualizing biochemical, genetic, or pharmacological processes in vivo and longitudinally in small animals. The overall goal of our academic-industrial partnership is to enable the molecular and cellular sensitivity of ultrasound-guided photoacoustic (USPA) imaging, furthering its development and translation into the preclinical research arena for longitudinal animal studies. Our hypothesis is that a non-invasive USPA imaging system, capable of simultaneous anatomical, functional, cellular and molecular visualization of cancer in small animals, will significantly enhance the outcome of fundamental and preclinical cancer research. The central theme of our application is to develop contrast agents and signal/image processing algorithms for USPA imaging to enable quantitative imaging of tumor angiogenesis and functional, cellular/molecular properties of tissue in small animal models of breast cancer. In this project we will specifically demonstrate our approach by developing imaging contrast agents sensitive to human epidermal growth factor receptor 2 (HER2) and the 1v23 integrin. These agents will be used to detect the molecular composition of a tumor in vivo to monitor the effect of the therapeutic small molecule tyrosine kinase inhibitor lapatinib on breast cancer cellular function and angiogenesis in longitudinal studies.
The development of small animal models of human diseases has created unparalleled opportunities for discovery of the molecular, biological and physiological basis of pathology. However, the use of animal models has not yet reached its full potential due to the limited availability of imaging techniques capable of monitoring therapy and providing simultaneous morphological, functional, and molecular quantitative imaging in vivo. Recently, ultrasound-guided photoacoustic imaging has been introduced where the ultrasound (US) is used primarily to visualize anatomical structures and photoacoustics (PA) aims at providing functional information about the tissue down to the cellular level. However, to enable the molecular sensitivity of ultrasound-guided photoacoustic (USPA) imaging, contrast agents with desired optical and targeting properties are required. Therefore, the fundamental premise of our program is to develop molecularly sensitive contrast agents to enable USPA imaging to simultaneously visualize anatomical, functional and molecular properties of tissue in vivo. The significance of such a tool is that researchers can use it to image the function of cells at a macroscopic level, assessing their response to therapy, without sacrificing the animal. Further significance of our approach is that once we build targeted, non-toxic, nano-sized contrast agents sensitive to pathology at the cellular level, our contrast agents can enable the molecular imaging capability of any available research or commercial USPA imaging system.
|Hannah, Alexander S; Luke, Geoffrey P; Emelianov, Stanislav Y (2016) Blinking Phase-Change Nanocapsules Enable Background-Free Ultrasound Imaging. Theranostics 6:1866-76|
|Luke, Geoffrey P; Hannah, Alexander S; Emelianov, Stanislav Y (2016) Super-Resolution Ultrasound Imaging in Vivo with Transient Laser-Activated Nanodroplets. Nano Lett 16:2556-9|
|Gray, J P; Dana, N; Dextraze, K L et al. (2016) Multi-Wavelength Photoacoustic Visualization of High Intensity Focused Ultrasound Lesions. Ultrason Imaging 38:96-112|
|Mallidi, Srivalleesha; Kim, Seungsoo; Karpiouk, Andrei et al. (2015) Visualization of molecular composition and functionality of cancer cells using nanoparticle-augmented ultrasound-guided photoacoustics. Photoacoustics 3:26-34|
|Luke, Geoffrey P; Myers, Jeffrey N; Emelianov, Stanislav Y et al. (2014) Sentinel lymph node biopsy revisited: ultrasound-guided photoacoustic detection of micrometastases using molecularly targeted plasmonic nanosensors. Cancer Res 74:5397-408|
|Kim, Seungsoo; Chen, Yun-Sheng; Luke, Geoffrey P et al. (2014) In-vivo ultrasound and photoacoustic image- guided photothermal cancer therapy using silica-coated gold nanorods. IEEE Trans Ultrason Ferroelectr Freq Control 61:891-7|
|Qu, Min; Mehrmohammadi, Mohammad; Truby, Ryan et al. (2014) Contrast-enhanced magneto-photo-acoustic imaging in vivo using dual-contrast nanoparticles. Photoacoustics 2:55-62|
|Hannah, Alexander; Luke, Geoffrey; Wilson, Katheryne et al. (2014) Indocyanine green-loaded photoacoustic nanodroplets: dual contrast nanoconstructs for enhanced photoacoustic and ultrasound imaging. ACS Nano 8:250-9|
|Joshi, Pratixa P; Yoon, Soon Joon; Hardin, William G et al. (2013) Conjugation of antibodies to gold nanorods through Fc portion: synthesis and molecular specific imaging. Bioconjug Chem 24:878-88|
|Bayer, Carolyn L; Kelvekar, Juili; Emelianov, Stanislav Y (2013) Influence of nanosecond pulsed laser irradiance on the viability of nanoparticle-loaded cells: implications for safety of contrast-enhanced photoacoustic imaging. Nanotechnology 24:465101|
Showing the most recent 10 out of 12 publications